Speaker Profile
President & CEO, Oncocyte Inc.
Biography
Ronnie has over 35 years of experience in the Global Clinical and Molecular Diagnostics industry. He currently serves as the President and CEO of Oncocyte Inc. In his early years in diagnostics, he worked for Abbott Diagnostics in sales and marketing, Immucor as VP of Marketing and Product Development, and the SVP Operations for Roche Molecular Diagnostics. In his most recent roles, he co-founded and served as Chief Executive Officer of Clarient, a public Molecular Pathology Lab which was sold to General Electric Healthcare in December 2010. After which, he became the President of the Medical Sciences Venture for Life Technologies, and post-acquisition by Thermo Fisher Scientific, he stepped into the President of the Genetic Science Division for Thermo. He is a passionate ambassador for democratization of molecular diagnostic testing into community-based environments to better manage deadly diseases like cancer.
Genomic Profiling Showcase:
Oncocyte Inc.
Oncocyte is a molecular diagnostics company providing actionable answers at critical decision points across the lung cancer care continuum, with the goal of improving patient outcomes by accelerating and optimizing diagnosis and treatment.
The Evolution of Precision Testing for Immunotherapy Selection and Monitoring for Therapeutic Response
Oncocyte has reduced a 2000 gene classifier to practice as a 27 gene panel called DetermaIO with relevant RNA’s from the entire tumor micro-environment and also has a complimentary blood based Tumor Naïve monitoring test to ensure comprehensive patient management.
